The company said it will make the test available in the coming weeks. Each kit will cost US$119 ($200). The kits will not be available in Maryland, New Jersey, New York and Rhode Island. Those states have laws prohibiting testing with at-home sample collection kits, according to LabCorp.
Initially, the Food and Drug Administration required healthcare workers wearing masks, gloves and other protective gear to collect all samples from potential coronavirus patients, usually by sticking a long swab down their nose or throat.
More recently, the FDA has endorsed the self-swab method. LabCorp's test is the first that allows it to be done at home without professional supervision.
FDA Commissioner Stephen Hahn said in a statement the agency authorised the self-swab test based on data showing it is "as safe and accurate as sample collection at a doctor's office, hospital or other testing site."
- AP